No. 218 Xinghu Street, Suzhou Industrial Park, Suzhou, Jiangsu, Not provided, China
Overview
Pulekang Pharmaceutical develops innovative drugs concentrating on autoimmune diseases and cancer indications. The company emphasizes biologic macromolecule drug development. Recently Pulekang received an investment of RMB 40 million. The round was invested solely by Shuanglu Pharma. The raised funds will be used to support R&D of Pulekang's ophthalmology clinical drug pipeline.
